Evidence map›Paper›PMID 26333836›Full record

ArticleOpen biology2015

Cell cycle progression is an essential regulatory component of phospholipid metabolism and membrane homeostasis.

Miguel Sanchez-Alvarez, Qifeng Zhang, Fabian Finger, Michael J O Wakelam, Chris Bakal

Open access · goldAbstract read
In one paragraph

Article in Open biology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
2.3field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 43 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. DHA Suppresses Hepatic Lipid AccumulationFrontiers in nutrition · 2021
    Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Miguel Sanchez-AlvarezDivision of Cancer Biology, Chester Beatty Laboratories, Institute of Cancer Research, 237 Fulham Road, London SW3 6JB, UK miguel.sanchez@cnic.es.
Qifeng ZhangLipidomics Facility, Babraham Institute, Cambridge CB22 3AT, UK.
Fabian FingerDivision of Cancer Biology, Chester Beatty Laboratories, Institute of Cancer Research, 237 Fulham Road, London SW3 6JB, UK.
Michael J O WakelamLipidomics Facility, Babraham Institute, Cambridge CB22 3AT, UK.
Chris BakalDivision of Cancer Biology, Chester Beatty Laboratories, Institute of Cancer Research, 237 Fulham Road, London SW3 6JB, UK cbakal@icr.ac.uk.
Institute of Cancer Research · GBBabraham Institute · GB

Funding

Biotechnology and Biological Sciences Research Council BB/J017450/1Biotechnology and Biological Sciences Research Council BBS/E/B/000C0417Cancer Research UK C37275/A20146
6 · The paper itself

Abstract

We show that phospholipid anabolism does not occur uniformly during the metazoan cell cycle. Transition to S-phase is required for optimal mobilization of lipid precursors, synthesis of specific phospholipid species and endoplasmic reticulum (ER) homeostasis. Average changes observed in whole-cell phospholipid composition, and total ER lipid content, upon stimulation of cell growth can be explained by the cell cycle distribution of the population. TORC1 promotes phospholipid anabolism by slowing S/G2 progression. The cell cycle stage-specific nature of lipid biogenesis is dependent on p53. We propose that coupling lipid metabolism to cell cycle progression is a means by which cells have evolved to coordinate proliferation with cell and organelle growth.

Indexed as

AnimalsCell CycleDrosophilaDrosophila ProteinsEndoplasmic ReticulumEndoplasmic Reticulum StressG2 Phase Cell Cycle CheckpointsInsulinLipid MetabolismMechanistic Target of Rapamycin Complex 1Multiprotein ComplexesPhosphatidylcholinesPhosphatidylethanolaminesRNA InterferenceRNA, Small InterferingS Phase Cell Cycle CheckpointsDrosophila ProteinsInsulinMechanistic Target of Rapamycin Complex 1Multiprotein ComplexesPhosphatidylcholinesphosphatidylethanolaminePhosphatidylethanolaminesRNA, Small InterferingSterol Regulatory Element Binding ProteinsThymidineTOR Serine-Threonine KinasesTumor Suppressor Protein p53cell cycle progressionDrosophilaendoplasmic reticulum homeostasislipidomicsphospholipid metabolismsterol response element binding proteins

Identifiers

PMID26333836
PMCPMC4593667
OpenAlexW2174388925

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.